ONPH (Oncology Pharma) Other Current Liabilities: $0.00 Mil (As of Dec. 2004)


What is Oncology Pharma Other Current Liabilities?

Oncology Pharma ONPH -2.14% Other Current Liabilities is $0.00 Mil as of Dec. 2004.

Oncology Pharma's other current liabilities for the quarter that ended in Dec. 2004 was $0.00 Mil.

Oncology Pharma Other Current Liabilities Related Terms

Oncology Pharma Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Oncology Pharma's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncology Pharma Other Current Liabilities Chart

Oncology Pharma Annual Data
Trend Jun96 Jun97 Jun98 Mar00 Mar01 Mar02 Mar03
Other Current Liabilities
Get a 7-Day Free Trial 0.07 0.29 0.00 0.00 0.00

Oncology Pharma Quarterly Data
Mar00 Jun00 Sep00 Dec00 Mar01 Jun01 Sep01 Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 0.00 0.00 0.00 0.00

Oncology Pharma Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.00 Mil mean?
Oncology Pharma (ONPH) has a Other Current Liabilities of $0.00 Mil as of Dec. 2004. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Oncology Pharma.
Is Oncology Pharma's Other Current Liabilities too high?
Oncology Pharma's current Other Current Liabilities is $0.00 Mil.
How does Oncology Pharma's Other Current Liabilities compare to TAUG and IMUN?
Oncology Pharma's Other Current Liabilities of $0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Diversified Financial Services company?
A good Other Current Liabilities depends on the Diversified Financial Services industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Oncology Pharma. Oncology Pharma's current Other Current Liabilities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncology Pharma stock overvalued right now?
Oncology Pharma (ONPH) has a current Other Current Liabilities of $0.00 Mil. The current Other Current Liabilities is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Oncology Pharma (ONPH), the current Other Current Liabilities is $0.00 Mil as of Dec. 2004. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oncology Pharma Business Description

Address 732 S 6TH Street, Suite R, Las Vegas, NV, USA, 89101
Oncology Pharma Inc is a shell company and currently has no operations.